Landfar Bio medicine Co (000504.SZ) Stock Price

Landfar Bio medicine Co Price

CLOSED
11.45
​
Market closed

Over the last 19 years Landfar Bio medicine Co grew revenue by 3.2% annually, reaching 415.94 M CNY. Earnings per share have grown at 14.1% per year over the last 19 years. For Landfar Bio medicine Co, the net margin of 6.9% is up versus -12.2% a few years ago.

Landfar Bio medicine Co stock price

Access this data via the Eulerpool API

Landfar Bio medicine Co business model & stock analysis

NanHua Bio-medicine Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 512 full-time employees. The Company’s biomedical business includes stem cell storage and technical services, stem cell treatment research, medical instrument purchasing & sales. The Company’s energy conservation & environmental protection business includes energy management company (EMC) contract energy management, build-transfer (BT), product sales, and sewage treatment. The firm is involved in other businesses related to aid and build project. The firm mainly conducts businesses within the domestic market.

Frequently asked questions about Landfar Bio medicine Co

Converted at the current exchange rate, the Landfar Bio medicine Co share trades at 1.52 EUR (11.45 CNY).

The revenue cannot currently be calculated for Landfar Bio medicine Co.

The profit cannot currently be calculated for Landfar Bio medicine Co.

The P/E ratio cannot be calculated for Landfar Bio medicine Co at the moment.

The P/S cannot be calculated for Landfar Bio medicine Co currently.

The Eulerpool Quality Score for Landfar Bio medicine Co is 5/10.

The ISIN of Landfar Bio medicine Co is CNE000000263. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Landfar Bio medicine Co is 000504.SZ. The ticker symbol is used to trade Landfar Bio medicine Co shares on the stock exchange.

Fair ValueTerminal
11.34 CNY
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
812,382.29 CNY
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
CNY
Initial public offering
Dec 8, 1992
ISIN
CNE000000263
Cusip
Y2981Q104
Market capitalization
3.78 B CNYMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
112.92
P/B Ratio
14.22
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
9.05 %
Last updated Oct 9, 2026, 2:26 AM

Landfar Bio medicine Co Peer Group

Landfar Bio medicine Co FIGI

000504:CH · BBG000BZ95F2000504:CS · BBG000BZ95Y1